- Home
- WVE vs LOMA Comparison
WVE vs LOMA Comparison
Compare WVE & LOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- LOMA
- Stock Information
- Founded
- WVE 2012
- LOMA 1926
- Country
- WVE Singapore
- LOMA Argentina
- Employees
- WVE N/A
- LOMA N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- LOMA Building Materials
- Sector
- WVE Health Care
- LOMA Industrials
- Exchange
- WVE Nasdaq
- LOMA Nasdaq
- Market Cap
- WVE 915.6M
- LOMA 916.1M
- IPO Year
- WVE 2015
- LOMA 2017
- Fundamental
- Price
- WVE $8.31
- LOMA $10.72
- Analyst Decision
- WVE Strong Buy
- LOMA Strong Buy
- Analyst Count
- WVE 14
- LOMA 2
- Target Price
- WVE $20.79
- LOMA $15.00
- AVG Volume (30 Days)
- WVE 3.6M
- LOMA 939.2K
- Earning Date
- WVE 11-07-2025
- LOMA 11-06-2025
- Dividend Yield
- WVE N/A
- LOMA N/A
- EPS Growth
- WVE N/A
- LOMA N/A
- EPS
- WVE N/A
- LOMA 0.37
- Revenue
- WVE $93,946,000.00
- LOMA $559,741,122.00
- Revenue This Year
- WVE N/A
- LOMA $22.92
- Revenue Next Year
- WVE $6.26
- LOMA $25.84
- P/E Ratio
- WVE N/A
- LOMA $29.47
- Revenue Growth
- WVE N/A
- LOMA N/A
- 52 Week Low
- WVE $5.28
- LOMA $7.04
- 52 Week High
- WVE $16.74
- LOMA $14.17
- Technical
- Relative Strength Index (RSI)
- WVE 56.37
- LOMA 67.57
- Support Level
- WVE $8.18
- LOMA $10.03
- Resistance Level
- WVE $9.75
- LOMA $10.82
- Average True Range (ATR)
- WVE 0.64
- LOMA 0.58
- MACD
- WVE 0.14
- LOMA 0.37
- Stochastic Oscillator
- WVE 48.94
- LOMA 80.15
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS
Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.